SB
Strategic Blueprint’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-3,788
| Closed | -$2.4M | – | 718 |
|
|
2025
Q1 | $2.4M | Sell |
3,788
-73
| -2% | -$46.3K | 0.13% | 154 |
|
|
2024
Q4 | $2.75M | Sell |
3,861
-226
| -6% | -$161K | 0.16% | 119 |
|
|
2024
Q3 | $4.3M | Sell |
4,087
-36
| -0.9% | -$37.8K | 0.27% | 89 |
|
|
2024
Q2 | $4.33M | Sell |
4,123
-53
| -1% | -$55.7K | 0.29% | 85 |
|
|
2024
Q1 | $4.02M | Sell |
4,176
-856
| -17% | -$824K | 0.29% | 85 |
|
|
2023
Q4 | $4.42M | Buy |
5,032
+106
| +2% | +$93.1K | 0.36% | 66 |
|
|
2023
Q3 | $4.05M | Buy |
4,926
+295
| +6% | +$243K | 0.37% | 62 |
|
|
2023
Q2 | $3.33M | Buy |
4,631
+131
| +3% | +$94.1K | 0.32% | 72 |
|
|
2023
Q1 | $3.7M | Buy |
4,500
+768
| +21% | +$631K | 0.38% | 59 |
|
|
2022
Q4 | $2.69M | Sell |
3,732
-99
| -3% | -$71.4K | 0.31% | 81 |
|
|
2022
Q3 | $2.64M | Sell |
3,831
-1,126
| -23% | -$776K | 0.32% | 79 |
|
|
2022
Q2 | $2.93M | Sell |
4,957
-170
| -3% | -$100K | 0.36% | 71 |
|
|
2022
Q1 | $3.58M | Sell |
5,127
-6,372
| -55% | -$4.45M | 0.42% | 56 |
|
|
2021
Q4 | $7.26M | Buy |
11,499
+2,312
| +25% | +$1.46M | 0.92% | 15 |
|
|
2021
Q3 | $5.56M | Buy |
9,187
+265
| +3% | +$160K | 0.86% | 20 |
|
|
2021
Q2 | $4.98M | Buy |
8,922
+4,468
| +100% | +$2.5M | 0.78% | 20 |
|
|
2021
Q1 | $2.11M | Buy |
+4,454
| New | +$2.11M | 0.45% | 56 |
|
|
2020
Q3 | – | Sell |
-489
| Closed | -$305K | – | 226 |
|
|
2020
Q2 | $305K | Buy |
+489
| New | +$305K | 0.11% | 123 |
|